Supplemental material
Human Vaccines & Immunotherapeutics
Volume 18, 2022 - Issue 1
Rotavirus – Research Paper
Potential impact and cost-effectiveness of injectable next-generation rotavirus vaccines in 137 LMICs: a modelling study
Frédéric Debelluta PATH, Center for Vaccine Innovation and Access, Geneva, SwitzerlandCorrespondence[email protected]
https://orcid.org/0000-0002-3027-2838View further author information
https://orcid.org/0000-0002-3027-2838View further author information, , William P. Hausdorffc PATH, Center for Vaccine Innovation and Access, Washington, DC, USA;d Faculté de Médecine, Université Libre de Bruxelles, Brussels, Belgiumhttps://orcid.org/0000-0001-6650-3960View further author information
https://orcid.org/0000-0001-6650-3960View further author information &